Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 7 days ago
Share
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)
270 patients around the world
Available in
Chile, United States
Merck Sharp & Dohme LLC
3
Research sites
270
Patients around the world
This study is for people with
Lupus
Systemic lupus erythematosus
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Centro de Estudios Clínicos e Investigaciones Médicas CeCim
Recruiting
View site
Paseo Bulnes 79, oficina 27, Santiago, Región Metropolitana
Centro de Estudios Clínicos e Investigaciones Médicas CeCim
Recruiting
View site
Paseo Bulnes 79, oficina 27, Santiago, Región Metropolitana
IC La Serena Research - La Serena
Recruiting
View site
Woodrow Wilson 1697, La Serena, Chile
IC La Serena Research - La Serena
Recruiting
View site
Woodrow Wilson 1697, La Serena, Chile
Centro Internacional de Estudios Clínicos - CIEC
Recruiting
View site
Calle Manzano 343, Oficina 410-411, Comuna de Recoleta, Región Metropolitana, 8420383
Centro Internacional de Estudios Clínicos - CIEC
Recruiting
View site
Calle Manzano 343, Oficina 410-411, Comuna de Recoleta, Región Metropolitana, 8420383
See details
Contact us
Contact us
Sponsor
Merck Sharp & Dohme LLC
Conditions
Systemic lupus erythematosus
Requirements
To 75 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06161116
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent